× ELPEN is one of the oldest Greek pharmaceutical companies, counting 55 years of dynamic presence in the field of medicines production. Founded in 1996, its Research, Educational & Experimental Center is the first biomedical research and education laboratory, set up by a private institution in Greece. ELPEN's long lasting research efforts have led to the innovative Elpenhaler® inhalation device, an invention of its President and founder, Mr. Dimitrios Pentafragkas. Elpenhaler® is an extremely effective therapeutic tool for the treatment of respiratory diseases such as asthma and Chronic Obstructive Pulmonary Disease. Elpenhaler® is licensed in 35 countries and has international patents in more than 100 countries.Thirty (30) medicines of ΕLPEN are exported to 18 European countries and 41 worldwide, being trusted by national health systems with extremely strict regulations. In 2012 ELPEN founded its subsidiary ELPEN Pharma GmbH in Germany, where it is already distinguished for the high quality of its medicines.